Patient group
|
ICU strategy
|
Costs
|
Incremental costs
|
QALYs
|
Incremental QALYs
|
Incremental C/E
|
Prob C/Ea
|
Distr C/Eb
|
---|
All (n = 30,712)
|
|
Reject
|
16,100
| |
6.1 (11.6)
| | | | |
|
Admit
|
34,800
|
18,700
|
7.7 (14.4)
|
1.6 (2.8)
|
11,600
|
0.95
|
5000
|
Medical (n = 17122)
|
|
Reject
|
15,300
| |
5.7 (10.9)
| | | | |
|
Admit
|
33,500
|
18,200
|
7.4 (13.8)
|
1.7 (2.9)
|
10,700
|
0.97
|
4600
|
Acute surgery (n = 9722)
|
|
Reject
|
16,200
| |
6.5 (12.9)
| | | | |
|
Admit
|
36,900
|
20,700
|
8.2 (15.8)
|
1.7 (2.9)
|
12,300
|
0.93
|
5400
|
Planned surgery (n = 3868)
|
|
Reject
|
19,200
| |
6.6 (11.5)
| | | | |
|
Admit
|
35,400
|
16,200
|
7.7 (13.4)
|
1.1 (1.9)
|
14,700
|
0.84
|
6500
|
- * The numbers are average extra costs in Euro or health gains in quality-adjusted life years (QALYs) per patient. Costs and QALYs were discounted at 4% annually (undiscounted QALYs in brackets)
-
aUsing a general cost-effectiveness threshold of €22,000/QALY
-
bResults after health gains were weighted according to the patient’s lifetime QALYs in case of general ward care (severity of disease)
-
C/E cost-effectiveness, Distr distribution-weighted, Prob probability